User profiles for Beth Shaz
 | Beth ShazDuke University Verified email at duke.edu Cited by 12578 |
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications for …
Issue Writing Committee is charged with reviewing, updating, and categorizing indications for …
[HTML][HTML] Deployment of convalescent plasma for the prevention and treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven …
Noninfectious transfusion-associated adverse events and their mitigation strategies
Blood transfusions are life-saving therapies; however, they can result in adverse events that
can be infectious or, more commonly, noninfectious. The most common noninfectious …
can be infectious or, more commonly, noninfectious. The most common noninfectious …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
…, ME Williams, Y Wu, BH Shaz - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis. …
charged with reviewing, updating and categorizating indications for therapeutic apheresis. …
Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …
…, J Schwartz, R Weinstein, BH Shaz - Journal of clinical …, 2010 - Wiley Online Library
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged
with a review and categorization of indications for therapeutic apheresis. Beginning with the …
with a review and categorization of indications for therapeutic apheresis. Beginning with the …
[HTML][HTML] A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
BACKGROUND Although convalescent plasma has been widely used to treat severe
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …
Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I …
CJ Dente, BH Shaz, JM Nicholas… - Journal of Trauma …, 2009 - journals.lww.com
Methods: A massive transfusion protocol (MTP) was designed to achieve a packed red blood
cell: FFP: platelet ratio of 1: 1: 1 We prospectively gathered demographic, transfusion, and …
cell: FFP: platelet ratio of 1: 1: 1 We prospectively gathered demographic, transfusion, and …
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients
BH Shaz, CJ Dente, J Nicholas, JB MacLeod… - …, 2010 - Wiley Online Library
BACKGROUND: Recent data from military and civilian centers suggest that mortality is
decreased in massive transfusion patients by increasing the transfusion ratio of plasma and …
decreased in massive transfusion patients by increasing the transfusion ratio of plasma and …
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for …
…, R Sarode, J Schwartz, BH Shaz… - Journal of Clinical …, 2007 - Wiley Online Library
The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged
with a review and categorization of indications for therapeutic apheresis. This elaborate …
with a review and categorization of indications for therapeutic apheresis. This elaborate …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …